Back To: Home : Featured Technology : High Throughput Screening

CLICK HERE FOR WHAT'S NEW IN:
 

Live-cell, real-time monitoring of cAMP kinetics
May 2008
SHARING OPTIONS:

Promega

Promega Corp. announces the launch of its cell-based biosensor technology, termed GloSensor Technology. The non-lytic, live-cell GloSensor cAMP Assay is the first application of the patent-pending technology, which features a genetically engineered form of firefly luciferase. The benefit to screeners and scientists alike will be more biologically relevant data captured directly from living cells. GloSensor cAMP Assay is the first bioluminescent cell-based biosensor for the direct, intracellular kinetic monitoring of cAMP, and ideally suited to HTS and uHTS applications. Because researchers simply combine cells, compounds and GloSensor cAMP Assay Reagent, the technology offers 'zero-step' assay potential.

Promega Corp.
608-274-4330
www.promega.com


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.